Rice Hall James & Associates’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.7M | Buy |
477,416
+9,530
| +2% | +$485K | 1.37% | 23 |
|
|
2025
Q4 | $23.3M | Sell |
467,886
-8,195
| -2% | -$398K | 1.28% | 24 |
|
|
2025
Q3 | $22.8M | Sell |
476,081
-48,566
| -9% | -$1.96M | 1.24% | 22 |
|
|
2025
Q2 | $16.5M | Buy |
524,647
+8,758
| +2% | +$281K | 0.89% | 32 |
|
|
2025
Q1 | $16.9M | Sell |
515,889
-12,456
| -2% | -$441K | 0.99% | 29 |
|
|
2024
Q4 | $19.1M | Sell |
528,345
-12,443
| -2% | -$438K | 1.05% | 28 |
|
|
2024
Q3 | $16.9M | Buy |
540,788
+38,202
| +8% | +$1.19M | 0.91% | 27 |
|
|
2024
Q2 | $13.4M | Sell |
502,586
-14,187
| -3% | -$411K | 0.81% | 33 |
|
|
2024
Q1 | $17.6M | Sell |
516,773
-13,179
| -2% | -$392K | 1.01% | 24 |
|
|
2023
Q4 | $15.3M | Sell |
529,952
-14,516
| -3% | -$385K | 0.89% | 34 |
|
|
2023
Q3 | $15M | Sell |
544,468
-10,325
| -2% | -$314K | 0.95% | 30 |
|
|
2023
Q2 | $16.7M | Buy |
554,793
+3,508
| +0.6% | +$123K | 0.95% | 32 |
|
|
2023
Q1 | $20M | Sell |
551,285
-68,042
| -11% | -$2.62M | 1.13% | 24 |
|
|
2022
Q4 | $22.1M | Sell |
619,327
-59,984
| -9% | -$2.08M | 1.27% | 17 |
|
|
2022
Q3 | $23M | Sell |
679,311
-154,641
| -19% | -$5.03M | 1.33% | 19 |
|
|
2022
Q2 | $24.1M | Sell |
833,952
-20,997
| -2% | -$601K | 1.17% | 24 |
|
|
2022
Q1 | $27.6M | Sell |
854,949
-1,906
| -0.2% | -$58.4K | 1.1% | 26 |
|
|
2021
Q4 | $25M | Sell |
856,855
-58,026
| -6% | -$1.76M | 0.89% | 35 |
|
|
2021
Q3 | $24.4M | Sell |
914,881
-7,978
| -0.9% | -$214K | 0.9% | 36 |
|
|
2021
Q2 | $28.4M | Sell |
922,859
-112,230
| -11% | -$3.44M | 1.01% | 30 |
|
|
2021
Q1 | $27.1M | Sell |
1,035,089
-2,289
| -0.2% | -$64K | 0.88% | 36 |
|
|
2020
Q4 | $26.1M | Buy |
1,037,378
+27,764
| +3% | +$598K | 0.92% | 37 |
|
|
2020
Q3 | $21M | Buy |
1,009,614
+84,128
| +9% | +$1.91M | 0.85% | 36 |
|
|
2020
Q2 | $22M | Sell |
925,486
-22,069
| -2% | -$488K | 0.94% | 32 |
|
|
2020
Q1 | $17M | Sell |
947,555
-14,418
| -1% | -$303K | 0.95% | 31 |
|
|
2019
Q4 | $22.8M | Buy |
961,973
+24,900
| +3% | +$605K | 0.77% | 36 |
|
|
2019
Q3 | $25.8M | Sell |
937,073
-414,213
| -31% | -$12.3M | 0.92% | 30 |
|
|
2019
Q2 | $44.7M | Buy |
1,351,286
+350,905
| +35% | +$12M | 1.49% | 14 |
|
|
2019
Q1 | $35.1M | Buy |
1,000,381
+86,645
| +9% | +$3.22M | 1.13% | 24 |
|
|
2018
Q4 | $30.4M | Buy |
913,736
+274,844
| +43% | +$11.8M | 1.11% | 24 |
|
|
2018
Q3 | $32.2M | Sell |
638,892
-163,769
| -20% | -$8.09M | 1.15% | 15 |
|
|
2018
Q2 | $48M | Sell |
802,661
-499,067
| -38% | -$25.9M | 1.75% | 7 |
|
|
2018
Q1 | $59.6M | Sell |
1,301,728
-20,886
| -2% | -$872K | 2.33% | 3 |
|
|
2017
Q4 | $52.7M | Buy |
1,322,614
+98,297
| +8% | +$3.88M | 2.07% | 3 |
|
|
2017
Q3 | $49M | Sell |
1,224,317
-137,056
| -10% | -$5.93M | 2.17% | 2 |
|
|
2017
Q2 | $58.7M | Buy |
1,361,373
+267,971
| +25% | +$9.54M | 2.55% | 1 |
|
|
2017
Q1 | $34.2M | Buy |
1,093,402
+11,662
| +1% | +$313K | 1.67% | 2 |
|
|
2016
Q4 | $27.3M | Buy |
1,081,740
+477,498
| +79% | +$10.7M | 1.38% | 5 |
|
|
2016
Q3 | $14.9M | Buy |
604,242
+60,636
| +11% | +$1.37M | 0.78% | 59 |
|
|
2016
Q2 | $11.1M | Buy |
543,606
+7,161
| +1% | +$127K | 0.64% | 69 |
|
|
2016
Q1 | $8.18M | Buy |
536,445
+59,377
| +12% | +$775K | 0.47% | 81 |
|
|
2015
Q4 | $6.41M | Buy |
477,068
+272,181
| +133% | +$4.21M | 0.37% | 84 |
|
|
2015
Q3 | $2.88M | Buy |
204,887
+92,698
| +83% | +$1.72M | 0.19% | 122 |
|
|
2015
Q2 | $1.91M | Buy |
+112,189
| New | +$1.6M | 0.11% | 201 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC